Important Safety Information for Clobex ® (clobetasol propionate) Lotion, %
Clobex ® (clobetasol propionate) Lotion, %, is not recommended for anyone younger than 18 years of age.
Clobex ® Lotion is indicated to treat steroid-responsive dermatoses. Treatment of steroid responsive dermatoses (eczema, dermatitis) should be limited to 2 weeks. Use only as directed by your physician, and do not apply to your face, underarms, or groin and avoid contact with your eyes and lips.
The total dosage should not exceed 50 g (50 mL or fl oz) per week. You should use Clobex ® Lotion only for the minimum period necessary to achieve desired results. In clinical trials, patients reported burning/stinging, skin dryness, irritation, redness, itching, skin thinning and widening of blood vessels. Because too much Lotion passing through your skin may affect your adrenal glands, do not use more than prescribed and stop using the product if you experience nausea, vomiting, fever or low blood pressure, and call you doctor. If you are pregnant, trying to get pregnant or nursing, speak to your doctor before using Clobex ® Lotion.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit /medwatch , or call 1-800-FDA-1088 (1-800-332-1088).
Psoriasis is a condition that affects the life cycle of skin cells. The condition causes cells to build up rapidly on the skin, causing itchy and dry red patches or thick, silvery scales. Psoriasis can cause pain in the joints, thickened nails and itching, burning or soreness. It is a persistent, long-term condition that comes in many types depending on where it is found in the body and which symptoms it causes. Psoriasis is related to T-cell immune responses that cause the body to attack healthy skin cells. Clobetasol propionate is used to treat mild to moderate psoriasis. It can help suppress the immune system, which gives the body time to heal. The cream is typically used on sensitive areas during outbreaks to help protect delicate areas of the body such as skin folds or the face.